| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/16/2003 | CN1105575C Lyophilized stem celi factor formulations |
| 04/16/2003 | CN1105574C Therapeutic uses of bactericidal/permeability increasing protein products |
| 04/16/2003 | CN1105573C Pharmaceutical composition |
| 04/16/2003 | CN1105557C Sustained releasable parenteral pharmaceutical preparations and method of producing same |
| 04/16/2003 | CA2407771A1 Mixtures for stimulating glucose up-take |
| 04/15/2003 | USRE38081 Method of hemodilution facilitated by monitoring oxygenation status |
| 04/15/2003 | US6548741 Developmental competence for assisted reproduction and nuclear transfer in pigs |
| 04/15/2003 | US6548739 Method for activating peroxisome proliferator activated receptor-γ |
| 04/15/2003 | US6548679 Antitumor agents |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548655 Interleukin-4 receptors |
| 04/15/2003 | US6548654 DNA encoding mammalian CX3C chemokine genes |
| 04/15/2003 | US6548653 Erythropoietin analog-human serum albumin fusion |
| 04/15/2003 | US6548651 Modified peptide nucleic acid (PNA) molecules |
| 04/15/2003 | US6548650 Nucleic acid encoding melanoma differentiation associated gene-9 |
| 04/15/2003 | US6548641 PTP 1D: a novel protein tyrosine phosphatase |
| 04/15/2003 | US6548639 IgG-binding protein from Staphylococcus and nucleotide sequence encoding this protein |
| 04/15/2003 | US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors |
| 04/15/2003 | US6548637 Endomorphine analog analgesics |
| 04/15/2003 | US6548636 Composition for use as viricide in prevention of viral infection |
| 04/15/2003 | US6548634 Peptidic composition linked to an oligomerization domain directly or through a linker or heparin binding domain; no homology to naturally occuring fibroblast growth factors (fgf) |
| 04/15/2003 | US6548633 Complementary DNA's encoding proteins with signal peptides |
| 04/15/2003 | US6548631 Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection |
| 04/15/2003 | US6548556 Stable enzymatic wound debrider |
| 04/15/2003 | US6548540 Administering dithiocarbamate thiolate anions to sensitize humans to conventional chemotherapy by blocking the p-glycoprotein membrane toxin extrusion pump |
| 04/15/2003 | US6548527 Treatments for immune-mediated ear disorders |
| 04/15/2003 | US6548501 Composition and methods for stimulating gastrointestinal motility |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/15/2003 | US6548482 Treatment of osteoporosis |
| 04/15/2003 | US6548481 A salt form of a dipeptide compound formed from an amino acid and a thiazolidine or pyrrolidine group, and the salts are selected from acetates, tartrates, fumarates, succinates, phosphates and sulfates |
| 04/15/2003 | US6548480 Reacting a phosphorylated derivatives with a dipeptide to displace halogen atom of phosphorylated derivative, deprotecting to form a phosphonic acid derivative; neutral endopeptidase and angiotensin converting enzyme inhibitor |
| 04/15/2003 | US6548479 Fused bicyclic peptides are administered to an animal to inhibit the proliferation of CD4 T-cells |
| 04/15/2003 | US6548478 Virginiamycin mixture |
| 04/15/2003 | US6548477 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 04/15/2003 | US6548475 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury |
| 04/15/2003 | US6548296 Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof |
| 04/15/2003 | US6548290 Geminin gene and protein |
| 04/15/2003 | US6548284 Membrane-bound metalloprotease and soluble secreted form thereof |
| 04/15/2003 | US6548281 Polypeptides, polynucleotides formed via recombination; for screening for antibacterial compounds |
| 04/15/2003 | US6548279 For polypeptides able to catalyze the enzymatic function of superoxide dismutase, carbonic anhydrase, or HIV protease |
| 04/15/2003 | US6548273 lacR from Streptococcus pneumoniae |
| 04/15/2003 | US6548272 Pathogenic gene for bipolar affective disorder |
| 04/15/2003 | US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering |
| 04/15/2003 | US6548269 A nucleotides that encode obesity receptor (ObR), a receptor protein that participates in mammalian body weight regualation; genetic engineering |
| 04/15/2003 | US6548262 Hemostasis system-related disorders treatment |
| 04/15/2003 | US6548258 Methods for diagnosing tuberous sclerosis by detecting mutation in the TSC-1 gene |
| 04/15/2003 | US6548077 Purifying type I collagen using two papain treatments and reducing and delipidation agents |
| 04/15/2003 | US6548068 Genetic engineered vaccine; gene coding antigen to disease and genetic engineerded viruses inserted into genome |
| 04/15/2003 | US6548067 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof |
| 04/15/2003 | US6548066 Inducing antibodies; antitumor agent |
| 04/15/2003 | US6548064 Polypeptide |
| 04/15/2003 | US6548063 Synferon |
| 04/15/2003 | US6548061 Repair central nervous system damage; kit containing complement fixing antibodies |
| 04/15/2003 | US6548060 Anti-apoptotic use of human glutaminyl-tRNA synthetase with two consecutive pro-apoptotic mediators |
| 04/15/2003 | US6548056 Autoimmune disease; anticancer agents |
| 04/15/2003 | US6548055 Activation cell in immunology system |
| 04/15/2003 | US6548049 Medicinal aerosol formulation |
| 04/15/2003 | CA2296466C Alatrofloxacin parenteral compositions |
| 04/15/2003 | CA2190485C Lacrimal gland specific emulsions for topical application to ocular tissue |
| 04/15/2003 | CA2117380C Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein |
| 04/15/2003 | CA2108018C Colloidal particles of water insoluble biologically active substances |
| 04/15/2003 | CA2059979C Complex containing coagulation factor ix |
| 04/15/2003 | CA2034504C Fungal stress proteins |
| 04/11/2003 | WO2002031131A1 Novel pla1 |
| 04/11/2003 | CA2425845A1 Novel pla1 |
| 04/10/2003 | WO2003029824A1 Method and agent for diagnosing and treating chronic inflammatory bowel diseases |
| 04/10/2003 | WO2003029814A2 Neuropilin/vegf c/vegfr 3 materials and methods |
| 04/10/2003 | WO2003029778A2 Novel secreted proteins and their uses |
| 04/10/2003 | WO2003029495A2 Coniosulphides and their derivatives, method for their production and use as medicaments |
| 04/10/2003 | WO2003029488A2 A method for the early detection of cancer |
| 04/10/2003 | WO2003029486A2 Single nucleotide polymorphisms predicting cardiovascular disease |
| 04/10/2003 | WO2003029482A2 Diagnosing, treating, and preventing cancer using cables |
| 04/10/2003 | WO2003029471A1 Muteins of apolipoprotein d |
| 04/10/2003 | WO2003029468A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 04/10/2003 | WO2003029467A1 Candidate protein for novel cell polarization factor and polynucleotide encoding the protein |
| 04/10/2003 | WO2003029463A2 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/10/2003 | WO2003029462A1 Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/10/2003 | WO2003029460A1 Polynucleotide fragments of an infectious human endogenous retrovirus |
| 04/10/2003 | WO2003029459A2 Micro-rna molecules |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029436A2 Ul16 binding protein 4 |
| 04/10/2003 | WO2003029429A2 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 04/10/2003 | WO2003029428A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/10/2003 | WO2003029426A2 Human and murine cytokine polypeptides |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029423A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/10/2003 | WO2003029422A2 Noonan syndrome gene |
| 04/10/2003 | WO2003029420A2 Apo-2 ligand variants and uses thereof |
| 04/10/2003 | WO2003029418A2 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |
| 04/10/2003 | WO2003029417A2 Nutrient medium for maintaining neural cells in injured nervous system |
| 04/10/2003 | WO2003029414A2 INTRODUCTION OF THE WLDs GENE FOR PREVENTION OF AXONAL DEGENERATION IN NEUROLOGICAL DISEASES |
| 04/10/2003 | WO2003029413A2 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | WO2003029412A2 Restricted expression lentivial vectors |
| 04/10/2003 | WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 04/10/2003 | WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | WO2003029406A2 USE OF HIF-1α VARIANTS TO ACCELERATE WOUND HEALING |
| 04/10/2003 | WO2003029403A2 Targeting proteins to cells expressing mannose receptors via expression in insect cells |
| 04/10/2003 | WO2003029401A2 Peptidoglycan recognition protein encoding nucleic acids and methods of use thereof |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |